Skip to main content
Scheme 1 | Journal of Nanobiotechnology

Scheme 1

From: Natural lipid nanoparticles extracted from Morus nigra L. leaves for targeted treatment of hepatocellular carcinoma via the oral route

Scheme 1

Schematic illustration of the transportation and therapeutic mechanism of MLNPs against HCC. After oral administration, MLNPs maintained stability during their passage through the GIT and modulated intestinal microbiota. The superior property effectively facilitated their unimpeded transit from the GIT into the hepatic vasculature via systemic circulation, ensuring comprehensive liver targeting. Subsequently, MLNPs underwent cellular internalization by liver tumor cells through the galactose-mediated endocytic processes. This intricate internalization mechanism further facilitated the efficacious eradication of Hepa1-6 cells by heightening intracellular oxidative stress, provoking mitochondrial damage, and inducing cell cycle arrest

Back to article page